ClinicalTrials.gg
Enrolling by invitationNCT07751354Updated Aug 7, 2026

Study of Measurement Properties of QTUG in Older Adults With Vestibulopathy

An interventional study of Vestibular Rehabilitation in Vestibulopathy, sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by Sheffield Teaching Hospitals NHS Foundation Trust · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Falls can be serious for older people, sometimes even leading to trips to the hospital. It's important to find ways to help prevent falls, especially for older people. Doctors have different tests they use to figure out who might be more likely to fall. One test they use is called the Time Up and Go (TUG) test, where a person has to stand up, walk a bit, and sit back down.

Now there's a newer version of this test called the quantitative TUG (QTUG), which uses special sensors to measure how well someone can keep their balance. But not many doctors use it yet because they're not sure how good it is compared to other tests. We want to study how good the QTUG is at measuring balance in older people with dizziness problems.

Study 1:

First, the Principal Investigator (PI) will look at data from previous routine tests done on 55 older adults seen within the regional department of Neurotology between 2018 and 2024 to see how the QTUG results match up with what the doctor already knows about balance problems.

Study 2:

Secondly, the PI will conduct a larger study with 120 older adults (+65 years) who have dizziness issues. Participants will be asked to undertake a variety of tests, including the QTUG test, 30 sec sit to stand test, and the PI will ask them questions about how they feel about their balance.

Study 3:

Sixty of the recruited 120 patients will do special exercises for six months to help improve their balance, while the other sixty will only do these exercises at the end of the study. The PI will then compare the data to see if the QTUG test can tell if exercises are helping or not.

Study 4:

Finally, the PI will recruit another 60 elderly participants to see if the QTUG test can tell who's more likely to fall over the next year. The PI will compare the results of the test to what happens to these people within a year to see how accurate the QTUG test is at predicting falls.

Using data from these studies, the PI hopes to learn if the QTUG test is a good way to measure balance problems in older people and if it can help doctors figure out who might be at risk of falling, and if the exercises are helping to prevent falls.

02

Conditions studied

  • Vestibulopathy
03

In context

Lead sponsor

Sheffield Teaching Hospitals NHS Foundation Trust is the lead sponsor of 214 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older adults (aged >65)
  • Diagnosis of vestibular pathology including unilateral vestibulopathy/vestibular neuritis or bilateral vestibulopathy, Meniere disease, vestibular associated migraines, PPPD, Presby vestibulopathy (PVP), vestibular paroxysmia, vestibular schwannoma, third window syndrome.
  • Able to walk independently with or without walking aid.
  • Able to provide consent

Exclusion criteria

Exclusion Criteria:

  • Visual impairment.
  • Diagnosis of Benign paroxysmal positional vertigo (BPPV) or haemodynamic dizziness (Postural hypotension, cardiogenic dizziness/POTS, heart arrythmia, heart attack).
  • Diagnosis of neurological disorder such as: multiple sclerosis, cerebrovascular accident, Parkinson's disease, dementia, diabetic neuropathy, epilepsy.
  • Not fluent in English.
  • Pregnant
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Intervention arm - Vestibular Rehabilitation

    60 participants will be randomised to receive vestibular rehabilitation that includes adaptive, habituation and substitution exercises; Gait retraining; Lower limb strengthening; Cervical spine treatment by a trained physiotherapist at the Royal Hallamshire Hospital Physiotherapy Department. This rehabilitation programme is delivered as part of routine care. The other 60 will be the control group, who will have their rehabilitation programme delayed until the end of the study 4.

    Behavioral: Vestibular Rehabilitation

  • No intervention
    Control arm

    60 participants will be randomised to the control group, who will have their rehabilitation programme delayed until the end of the study

Interventions

  • BehavioralVestibular Rehabilitation

    60 participants will be randomised to receive vestibular rehabilitation that includes adaptive, habituation and substitution exercises; Gait retraining; Lower limb strengthening; Cervical spine treatment by a trained physiotherapist at the Royal Hallamshire Hospital Physiotherapy Department. This rehabilitation programme is delivered as part of routine care.

06

What researchers measure

Primary outcomes

  1. Falls Risk Estimate (FRE)

    A statistical percentage (0% to 100%) indicating a patient's statistical risk of falling, compared to independent reference samples based on age and gender

    Time frame: From participant enrolment to completion of the intervention at 6 months

  2. Frailty Index (FI)

    An objective estimate (often based on Fried's frailty phenotype) that categorizes the patient's level of frailty (e.g., robust, pre-frail, or frail)

    Time frame: From participant enrolment to completion of the intervention at 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2026 (actual). Primary completion is estimated for Apr 2027, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2026
First posted
Aug 7, 2026
StartActual
May 12, 2026
Primary completionEst.
Apr 1, 2027
CompletionEst.
Apr 30, 2028
Last update
Aug 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07751354
Responsible party
Sponsor
First posted
Aug 7, 2026
Start date
May 12, 2026
Primary completion
Apr 1, 2027 (estimated)
Completion
Apr 30, 2028 (estimated)
Last update
Aug 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion